[Range of application of the endolymphatic radioisotope therapy with P-32 in malignant diseases of the lymphatic system].
D000368:Aged; D005260:Female; D006689:Hodgkin Disease / Q000532:radiotherapy; D006801:Humans; D008198:Lymph Nodes; D008207:Lymphatic Metastasis / Q000532:radiotherapy; D008220:Lymphography; D008223:Lymphoma / Q000532:radiotherapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000532:radiotherapy; D008297:Male; D008545:Melanoma / Q000532:radiotherapy; D009369:Neoplasms / Q000532:radiotherapy; D010759:Phosphorus Isotopes / Q000008:administration & dosage*
D010759:Phosphorus Isotopes
Uber den Anwendungsbereich der endolymphatischen Radioisotopentherapie mit P-32 bei malignen Erkrankungen des lymphatischen Systems.